Published in Lab Law Weekly, April 22nd, 2005
The 2000 Declaration of Helsinki, produced by 82 national medical associations, states that, "At the conclusion of the study, every patient entered into the study should be assured of access to the best proven prophylactic, diagnostic and therapeutic methods identified in the study" and places some limits on the use of placebos in studies conducted in developing countries.
Current FDA regulations require studies submitted in support of a new drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.